ICICI Prudential US Bluechip Equity Fund Direct Growth

ICICI Prudential US Bluechip Equity Fund Direct Growth

Equity

Direct

Global - Other

NAV as on 11-03-2025

₹ 68.41

-1.3%

1D

Inception Returns

16.4%

/yr

About ICICI Prudential US Bluechip Equity Fund Direct Growth

ICICI Prudential US Bluechip Equity Fund Direct Growth is an equity fund. This fund was started on 2 January, 2013. The fund is managed by Ritesh Lunawat. The fund could potentially beat inflation in the long-run.

Key Parameters

  1. ICICI Prudential US Bluechip Equity Fund Direct Growth has ₹3249 Cr worth of assets under management (AUM) as on Jan 2025 and is more than category average.
  2. The fund has an expense ratio 1.2.

Returns

ICICI Prudential US Bluechip Equity Fund Direct Growth has given a CAGR return of 16.36% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 9.06%, 13.58% and 18.13% respectively.

Holdings

ICICI Prudential US Bluechip Equity Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Consumer Defensive, Industrial, Tech, Financial Services, Communication, Consumer Cyclical, Basic Materials, Energy. Its top holdings are Gilead Sciences Inc, Altria Group Inc, The Walt Disney Co, Bristol-Myers Squibb Co, Corteva Inc

Taxation

As it is a global - other mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 20%
For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefit
Dividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.

Investment objective of ICICI Prudential US Bluechip Equity Fund Direct Growth

The investment objective of ICICI Prudential US Bluechip Equity Fund is to provide long term capital appreciation to investors by primarily investing in equity and equity related securities of companies listed on recognized stock exchanges in the United States of America. The Scheme shall also invest in ADRs/GDRs issued by Indian and foreign companies. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

Minimum Investment and lockin period

Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 100.00. ICICI Prudential US Bluechip Equity Fund Direct Growth has no lock in period.

Historical NAV & Returns

Absolute

zero opening, trading, fund transfer fee
5921 people have invested ₹ 1.3Cr in ICICI Prudential US Bluechip Equity Fund Direct Growth in the last three months

INDmoney Rank for ICICI Prudential US Bluechip Equity Fund Direct Growth

Powered by IND quant engine
IND ranking is not available for this fund.
img
Larger AUM within category
img
Beats FD returns for both 3Y & 5Y duration
img
No bad points found for this fund.

ICICI Prudential US Bluechip Equity Fund Direct Growth Overview

Expense ratio1.24%
Benchmark
S&P 500 TR USD
AUM₹3249 Cr
Inception Date2 January, 2013
Min Lumpsum/SIP--/--
Exit Load
1.0%
Lock InNo Lock-in
TurnOver
59.41%
STCGIf held for less than 24 months - slab rates.
LTCGIf held for more than 24 months - 12.5% without indexation.
Risk
Risk meter
pointer
Very High Risk

Trailing Returns

as on (11-Mar-25)

Period
ICICI Prudential US Bluechip Equity Fund Direct Growth
Global - Other Index
1M
-0.9%
-
3M
-3.3%
-
6M
0.5%
-
1Y
9.1%
-
3Y
13.6%
-
5Y
18.1%
-

Fund Distribution

as on (31-Jan-25)

  • Equity 98.1%

  • Debt & Cash 1.9%

Sector Allocation

Jan'25

Dec'24

Nov'24

Health
27.2%
Industrial
15.6%
Tech
14.9%
Consumer Defensive
14.4%
Financial Services
8.6%
Communication
6.6%
Consumer Cyclical
6.1%
Basic Materials
5.9%
Energy
0.6%
  • Equity

Holdings
Weight%
1M Change
Gilead Sciences Inc
Gilead Sciences Inc
3.19%
0%
Altria Group Inc
Altria Group Inc
2.91%
0%
The Walt Disney Co
The Walt Disney Co
2.85%
0%
Bristol-Myers Squibb Co
Bristol-Myers Squibb Co
2.8%
0%
Corteva Inc
Corteva Inc
2.79%
0%
Fund
Jan'25
Dec'24
Nov'24
No of Holdings
64
64
64
Top 5 Company Concentration
13.7%
13.4%
13.5%
Company having highest exposure
Gilead Sciences Inc (2.9%)
Gilead Sciences Inc (2.8%)
Altria Group Inc (2.8%)
No of Sectors
9
9
9
Top 5 Sectors Concentration
80.7%
80.9%
79.7%
Sector having highest exposure
Health (27.2%)
Health (26.3%)
Health (22.5%)
Loading...
We are taking more time than usual
Ritesh Lunawat
Ritesh Lunawat
Fund Manager of ICICI Prudential US Bluechip Equity Fund Direct Growth, since 13 September 2024
Fund House
ICICI Prudential Asset Management Company Limited
Total Schemes
Total AUM
₹8.31L Cr
as on 31-Jan-2025
Address
ICICI Prudential Asset Mgmt.Company Limited,3rd Floor, Hallmark Business Plaza,,Sant Dyaneshwar Marg,,Bandra (East)
Phone
+912226428000
Website
investor.helpdesk@hdfcbank.com

Mutual Fund Insights

Insights icon
In the last 3 years, Mirae Asset NYSE FANG+ ETF Fund of Fund Direct Growth has given 35.9% return, outperforming this fund by 22.32% per annum.
Insights icon
In the last 1 year, Mirae Asset Hang Seng TECH ETF Fund of Fund Direct Growth has given 106.6% return, outperforming this fund by 97.54%.
Insights icon
In the last 5 years, Motilal Oswal Nasdaq 100 Fund of Fund Direct Growth has given 24.11% return, outperforming this fund by 5.98% per annum.

ICICI Prudential US Bluechip Equity Fund Direct Growth Highlights

Risk meter
pointer

Very High Risk

Investors understand that their principal will be at Very High Risk
About the fund

About the fund

This fund has delivered an average annual returns of 16.36% since inception which is more than its category average return of 8.25%
Fund Allocations

Fund Allocations

This fund has an allocation of 98.08% in Equity, 0% in Debt and 1.92% in Cash related instruments
AUM size ₹3249 Cr

AUM size ₹3249 Cr

This fund has AUM of ₹3249 Cr which is more than its category average of ₹ 619 Cr
Expense Ratio 1.24%

Expense Ratio 1.24%

This fund has an expense ratio of 1.24% which is less than its category average expense ratio of 1.38%

Frequently Asked Questions for ICICI Prudential US Bluechip Equity Fund Direct Growth

The current NAV of ICICI Prudential US Bluechip Equity Fund Direct Growth is ₹68.41 as on 11-Mar-2025.
Existing (Absolute + CAGR) as on 11-Mar-2025.
ICICI Prudential US Bluechip Equity Fund Direct Growth
Absolute Returns
CAGR Returns
1 Month Returns
-0.85%
-0.85%
6 Month Returns
0.53%
0.53%
1 Year Returns
9.06%
9.06%
3 Years Returns
46.51%
13.58%
5 Years Returns
130.05%
18.13%
With INDmoney, the process of investing is very simple and involves zero commission.
  • Click Buy on the fund name.
  • Input the amount you are looking to invest.
  • Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
  • Select your bank account and proceed with Payment.
1.24% as on February 2025
₹3249 Cr as on February 2025
Gilead Sciences Inc(3.19%), Altria Group Inc(2.91%), The Walt Disney Co(2.85%), Bristol-Myers Squibb Co(2.8%), Corteva Inc(2.79%) as on February 2025
Health(26.03%), Consumer Defensive(15.31%), Industrial(15.26%) as on February 2025
The alpha ratio for the ICICI Prudential US Bluechip Equity Fund Direct Growth for various period is as follows:
Fund Name
Alpha 1 Year
Alpha 3 Years
Alpha 5 Years
ICICI Prudential US Bluechip Equity Fund Direct Growth
-10.56
-5.3
-3.27
As on February 2025
The alpha for ICICI Prudential US Bluechip Equity Fund Direct Growth is calculated against S&P 500 TR USD. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the ICICI Prudential US Bluechip Equity Fund Direct Growth for various period is as follows:
Fund Name
Beta 1 Year
Beta 3 Years
Beta 5 Years
ICICI Prudential US Bluechip Equity Fund Direct Growth
0.91
1.06
0.98
As on February 2025
The Beta for ICICI Prudential US Bluechip Equity Fund Direct Growth is calculated with S&P 500 TR USD. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the ICICI Prudential US Bluechip Equity Fund Direct Growth for various period is as follows:
Fund Name
Sharpe Ratio 1 Year
Sharpe Ratio 3 Years
Sharpe Ratio 5 Years
ICICI Prudential US Bluechip Equity Fund Direct Growth
0.35
0.4
0.69
As on February 2025
The sharpe ratio for ICICI Prudential US Bluechip Equity Fund Direct Growth is calculated with S&P 500 TR USD. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the ICICI Prudential US Bluechip Equity Fund Direct Growth for various period is as follows:
Fund Name
Standard Deviation 1 Year
Standard Deviation 3 Years
Standard Deviation 5 Years
ICICI Prudential US Bluechip Equity Fund Direct Growth
12.3
18.39
17.56
As on February 2025
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sortino ratio is 0.64 as on February 2025. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.
Ritesh Lunawat is the fund manager of ICICI Prudential US Bluechip Equity Fund Direct Growth
The Exit load of ICICI Prudential US Bluechip Equity Fund Direct Growth is 1%